Stock Weekly: Medicenna Therapeutics (MDNA:CAD5.20) sinks 5.1%
CANADIAN WEEKLY STOCK REPORT
Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 12th largest Biotechnology company by market cap, has dropped 28.0c (or 5.1%) in the past week to close at CAD5.20. Compared with the S&P/TSX 60 Index which fell 6.2 points (or 0.6%) in the week, this represented a relative price change of -4.5%. The stock fell for a third week on Friday bringing its a three-week fall to 87.0c or 14.3%.
The price ranged between a low of CAD5.22 on Wednesday, Jan 13 and a ...